PI-RADS 2.1 分类的多变量分层用于靶向穿刺假阳性风险:对前列腺穿刺决策的影响
该回顾性研究纳入221例接受3.0 T/1.5 T多参数MRI的男性,构建多变量模型预测PI-RADSv2.1≥3分病灶靶向穿刺假阳性(即无临床显著前列腺癌,ISUP≥2)。与年龄<65岁、PSAD<0.15 ng/mL/mL、多灶性独立相关,模型AUC 0.815;调整后MRI对csPCa敏感度87.5%、特异度79.9%,在阈值概率≥15%时决策分析净获益优于未调整或仅调整PSAD。
要点
- 年龄<65岁(OR 2.77)和PSAD<0.15 ng/mL/mL(OR 2.45)与靶向穿刺假阳性独立相关。
- PI-RADS 4/5类 vs 3类的OR分别为0.15/0.07,多灶性OR 0.46。
- 模型调整后MRI对csPCa敏感度87.5%、特异度79.9%,AUC 0.815。
核心结论
- 依据多变量假阳性风险调整PI-RADSv2.1分类,在触发指标病灶靶向穿刺方面可能比未调整分类或仅调整PSAD更有效。
研究设计与样本
- 回顾性纳入2019年4月至2021年7月间221例有或无既往阴性前列腺穿刺、因疑似临床显著前列腺癌行3.0 T/1.5 T多参数MRI的男性;由研究协调员修订两位放射科医师(分别有>1500/>500例mpMRI经验)的報告,并与经会阴系统穿刺加PI-RADSv2.1≥3病灶融合靶向穿刺或PI-RADSv2.1≤2但临床风险较高男性的结果匹配;构建多变量模型预测指标病灶靶向穿刺假阳性(定义为无csPCa,ISUP≥2),采用bootstrap内部验证、ROC分析和决策分析。
诊断标准与关键数值
- 靶向穿刺假阳性定义为指标病灶无临床显著前列腺癌(ISUP≥2);与假阳性显著相关的因素:年龄<65岁(OR 2.77)、PSAD<0.15 ng/mL/mL(OR 2.45)、PI-RADS 4类 vs 3类(OR 0.15)、PI-RADS 5类 vs 3类(OR 0.07)、多灶性(OR 0.46);模型评估假阳性的AUC为0.815;调整PI-RADSv2.1分类后,mpMRI对csPCa的敏感度87.5%、特异度79.9%;决策分析中从阈值概率≥15%起,调整模型的净获益大于未调整分类或仅调整PSAD。
临床应用与阅片要点
- 作者认为,依据多变量假阳性风险调整PI-RADSv2.1分类,在触发指标病灶靶向穿刺方面可能比未调整PI-RADS分类或仅调整PSAD更有效。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To identify clinical and multiparametric magnetic resonance imaging (mpMRI) factors predicting false positive target biopsy (FP-TB) of prostate imaging reporting and data system version 2.1 (PI-RADSv2.1) ≥ 3 findings.
METHOD: We retrospectively included 221 men with and without previous negative prostate biopsy who underwent 3.0 T/1.5 T mpMRI for suspicious clinically significant prostate cancer (csPCa) between April 2019-July 2021. A study coordinator revised mpMRI reports provided by one of two radiologists (experience of > 1500/>500 mpMRI examinations, respectively) and matched them with the results of transperineal systematic biopsy plus fusion target biopsy (TB) of PI-RADSv2.1 ≥ 3 lesions or PI-RADSv2.1 ≤ 2 men with higher clinical risk. A multivariable model was built to identify features predicting FP-TB of index lesions, defined as the absence of csPCa (International Society of Urogenital Pathology [ISUP] ≥ 2). The model was internally validated with the bootstrap technique, receiving operating characteristics (ROC) analysis, and decision analysis.
RESULTS: Features significantly associated with FP-TB were age < 65 years (odds ratio [OR] 2.77), prostate-specific antigen density (PSAD) < 0.15 ng/mL/mL (OR 2.45), PI-RADS 4/5 category vs. category 3 (OR 0.15/0.07), and multifocality (OR 0.46), with a 0.815 area under the curve (AUC) in assessing FP-TB. When adjusting PI-RADSv2.1 categorization for the model, mpMRI showed 87.5% sensitivity and 79.9% specificity for csPCa, with a greater net benefit in triggering biopsy compared to unadjusted categorization or adjustment for PSAD only at decision analysis, from threshold probability ≥ 15%.
CONCLUSION: Adjusting PI-RADSv2.1 categories for a multivariable risk of FP-TB is potentially more effective in triggering TB of index lesions than unadjusted PI-RADS categorization or adjustment for PSAD alone.
引用
- Girometti, Giannarini, De Martino, et al. Multivariable stratification of PI-RADS version 2.1 categories for the risk of false-positive target biopsy: Impact on prostate biopsy decisions. Eur J Radiol. 2023. PMID: 37300933. doi:10.1016/j.ejrad.2023.110897
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。